title: Low-power polling mode of the next-generation IMES2 implantable wireless EMG sensor.
abstract: The IMES1 Implantable MyoElectric Sensor device is currently in human clinical trials led by the Alfred Mann Foundation. The IMES is implanted in a residual limb and is powered wirelessly using a magnetic field. EMG signals resulting from the amputee's voluntary movement are amplified and transmitted wirelessly by the IMES to an external controller which controls movement of an external motorized prosthesis. Development of the IMES technology is on-going, producing the next-generation IMES2. Among various improvements, a new feature of the IMES2 is a low-power polling mode. In this low-power mode, the IMES2 power consumption can be dramatically reduced when the limb is inactive through the use of a polled sampling. With the onset of EMG activity, the IMES2 system can switch to the normal higher sample rate to allow the acquisition of high-fidelity EMG data for prosthesis control.
authors.forename: Glenn A
authors.initials: GA
authors.lastname: DeMichele
authors.forename: Zhe
authors.initials: Z
authors.lastname: Hu
authors.forename: Philip R
authors.initials: PR
authors.lastname: Troyk
authors.forename: Hongnan
authors.initials: H
authors.lastname: Chen
authors.forename: Richard F ff
authors.initials: RF
authors.lastname: Weir
mesh_terms: D000674:Amputees / Q000534:rehabilitation*; D004576:Electromyography; D006801:Humans; D060526:Magnetic Fields; D008297:Male; D019919:Prosthesis Implantation; D012371:Robotics / Q000295:instrumentation; D013686:Telemetry; D059015:Wireless Technology; D055815:Young Adult